A review on the effect of COVID-19 in type 2 asthma and its management.

导出 OA

翻译打印收藏纠错

作者： Srijit,Ghosh ^[1] ; Srijita,Das ^[2] ; Rupsa,Mondal ^[1] ; Salik,Abdullah ^[1] ; Shirin,Sultana ^[1] ; Sukhbir,Singh ^[3] ; Aayush,Sehgal ^[3] ; Tapan,Behl ^[4]

作者单位： Guru Nanak Institute of Pharmaceutical Science and Technology, Panihati, Sodepur, Kolkata 700114, West Bengal, India. ^[1] Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi 835215, Jharkhand, India. ^[2] Chitkara College of Pharmacy, Chitkara University, Patiala 140401, Punjab, India. ^[3] Chitkara College of Pharmacy, Chitkara University, Patiala 140401, Punjab, India. Electronic address: tapan.behl@chitkara.edu.in. ^[4]

关键词 COVID-19 Cytokines Inflammation SARS-CoV-2 T-cells Type-2 asthma

主题词动物(Animals);哮喘(Asthma);细胞因子类(Cytokines);疾病恶化(Disease Progression);人类(Humans);疾病大流行(Pandemics);危险因素(Risk Factors)

DOI 10.1016/j.intimp.2020.107309

PMID 33385710

发布时间 2022-12-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交